Brief: Shenzhen Hepalink Pharmaceutical Group Proposes To Appoint Zhang Ping As Executive Director
29/03/2023 15:20
March 29 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd 002399.SZ :
* PROPOSES TO APPOINT ZHANG PING AS EXECUTIVE DIRECTOR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical
See all newsBrief: HEPALINK 9M Revenue RMB3,796.9 Million
Brief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina